glycyrrhizic acid has been researched along with lamivudine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujii, N; Harada, M; Kiura, K; Matsuo, K; Shimomura, H; Shinagawa, K; Takenaka, K | 1 |
| Sata, M; Ueno, T | 1 |
| Hachimine, D; Nakahashi, Y; Okazaki, K; Seki, T; Wakamatsu, T | 1 |
| Jain, AK; Jain, N; Mishra, D; Rajoriya, V | 1 |
1 review(s) available for glycyrrhizic acid and lamivudine
| Article | Year |
|---|---|
[Forefront of therapy for hepatic fibrosis].
Topics: Animals; Drugs, Chinese Herbal; Genetic Therapy; Glycyrrhizic Acid; Humans; Interferon-alpha; Interferon-beta; Lamivudine; Liver Cirrhosis; Liver Cirrhosis, Experimental; Mice; Rats | 2002 |
3 other study(ies) available for glycyrrhizic acid and lamivudine
| Article | Year |
|---|---|
Lamivudine and glycyrrhizin for treatment of chemotherapy-induced hepatitis B virus (HBV) hepatitis in a chronic HBV carrier with non-Hodgkin lymphoma.
Topics: Anti-HIV Agents; Antineoplastic Agents; Chronic Disease; DNA, Viral; Drug Therapy, Combination; Glycyrrhizic Acid; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Reverse Transcriptase Inhibitors; Testicular Neoplasms; Virus Activation | 2001 |
The combination of glycyrrhizin and lamivudine can reverse the cisplatin resistance in hepatocellular carcinoma cells through inhibition of multidrug resistance-associated proteins.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Hepatocellular; Cell Line, Tumor; Cisplatin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Glycyrrhizic Acid; Humans; Lamivudine; Liver Neoplasms; Membrane Transport Proteins; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Reverse Transcriptase Polymerase Chain Reaction | 2007 |
Glycyrrhizin conjugated chitosan nanoparticles for hepatocyte-targeted delivery of lamivudine.
Topics: Animals; Anti-Retroviral Agents; Chitosan; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Glycyrrhizic Acid; Hepatocytes; Lamivudine; Molecular Weight; Nanoparticles; Particle Size; Rats; Tissue Distribution | 2014 |